Literature DB >> 28848825

The COPD Pipeline, XXV.

Nicholas Gross1.   

Abstract

Keywords:  Ataluren; COPD drug development; COPD pipeline; Nemonoxacin; aerosol drugs; influenza vaccines; orphan drugs; quadrivalent vaccine

Year:  2014        PMID： 28848825      PMCID： PMC5556869          DOI： 10.15326/jcopdf.1.2.2014.0143

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  5 in total

1.  The COPD pipeline VII.

Authors:  Nicholas J Gross
Journal:  COPD       Date:  2010-12       Impact factor: 2.409

Review 2.  Pulmonary vaccine delivery: a realistic approach?

Authors:  Wouter F Tonnis; Gideon F Kersten; Henderik W Frijlink; Wouter L J Hinrichs; Anne H de Boer; Jean-Pierre Amorij
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-08-02       Impact factor: 2.849

3.  The COPD pipeline.

Authors:  Yasser Mushtaq
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

4.  Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Eitan Kerem; Michael W Konstan; Kris De Boeck; Frank J Accurso; Isabelle Sermet-Gaudelus; Michael Wilschanski; J Stuart Elborn; Paola Melotti; Inez Bronsveld; Isabelle Fajac; Anne Malfroot; Daniel B Rosenbluth; Patricia A Walker; Susanna A McColley; Christiane Knoop; Serena Quattrucci; Ernst Rietschel; Pamela L Zeitlin; Jay Barth; Gary L Elfring; Ellen M Welch; Arthur Branstrom; Robert J Spiegel; Stuart W Peltz; Temitayo Ajayi; Steven M Rowe
Journal:  Lancet Respir Med       Date:  2014-05-15       Impact factor: 30.700

Review 5.  Review of nemonoxacin with special focus on clinical development.

Authors:  Xiaohua Qin; Haihui Huang
Journal:  Drug Des Devel Ther       Date:  2014-07-05       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.